| abstract |
This disclosure provides improved Iipid-based compositions, including lipid nanoparticle compositions, and methods of use thereof for delivering nucleic acids in vivo . These compositions have reduced immune activation resulting in accelerated blood clearance and/or anti-drug antibodies and they have an improved toxicity profile and therapeutic index in vivo. |